UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058089
Receipt number R000066034
Scientific Title Values of terminally ill patients with cancer and their families in decision-making regarding artificial hydration: A scoping review
Date of disclosure of the study information 2025/06/05
Last modified on 2025/06/05 11:40:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Values of terminally ill patients with cancer and their families in decision-making regarding artificial hydration: A scoping review

Acronym

Values of terminally ill patients with cancer and their families in decision-making regarding artificial hydration: A scoping review

Scientific Title

Values of terminally ill patients with cancer and their families in decision-making regarding artificial hydration: A scoping review

Scientific Title:Acronym

Values of terminally ill patients with cancer and their families in decision-making regarding artificial hydration: A scoping review

Region

Japan


Condition

Condition

Cancer

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify what values are important to terminally ill patients with cancer and their families in decision-making regarding artificial hydration

Basic objectives2

Others

Basic objectives -Others

To map values important to terminally ill patients with cancer and their families in decision-making regarding artificial hydration

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Values important to terminally ill patients with cancer and their families in decision-making regarding artificial hydration

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Studies involving terminally ill cancer patients and/or their families (including bereaved family members), accounting for at least 50% of participants.
2. Describes values, ethical issues, or psychosocial aspects that are important in decision-making regarding artificial hydration at the end of life.
3. The above aspects are presented from the perspective of the patients and/or their families (including bereaved family members).
4. Peer-reviewed research articles published by academic publishers or societies, and indexed in academic databases such as PubMed, Cochrane Library, CINAHL, PsycInfo, or Ichushi.

Key exclusion criteria

1. Studies involving patients undergoing active cancer treatment (e.g., chemotherapy, radiotherapy, surgery, immunotherapy), or studies with fewer than 10 participants.
2. Studies not related to palliative care, or those focusing solely on the physiological effects of hydration.
3. Studies published only as conference abstracts, editorials, letters, comments, books, textbooks, professional practice journals, commercial magazines, narrative reviews, expert consensus guidelines, or in journals mainly consisting of non-peer-reviewed educational content.
4. No exclusion criteria will be applied based on study design.

Target sample size



Research contact person

Name of lead principal investigator

1st name Sakiko
Middle name
Last name Wada

Organization

Nagoya City University Hospital

Division name

Center for Psycho-oncology and Palliative Care

Zip code

467-8602

Address

1, Kawasumi Mizuho-cho, Mizuho-ku, Nagoya

TEL

052-851-5511

Email

saki.lala.1025@gmail.com


Public contact

Name of contact person

1st name Sakiko
Middle name
Last name Wada

Organization

Nagoya City University Hospital

Division name

Center for Psycho-oncology and Palliative Care

Zip code

467-8602

Address

1, Kawasumi Mizuho-cho, Mizuho-ku, Nagoya

TEL

052-851-5511

Homepage URL


Email

saki.lala.1025@gmail.com


Sponsor or person

Institute

Nagoya City University Hospital

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Not applicable

Address

Not applicable

Tel

052-851-5511

Email

saki.lala.1025@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

愛知県


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 03 Day

Date of IRB


Anticipated trial start date

2024 Year 10 Month 04 Day

Last follow-up date

2028 Year 10 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We will search the following electronic databases: PubMed, CENTRAL, CDSR, CINAHL, PsycInfo and Ichushi-Web of the Japan Medical Abstracts Society.
The title and abstracts of retrieved articles in the peer-reviewed scientific literature will be screened by two members of the research team, who will apply the inclusion/exclusion criteria based on the title and abstract listing. For those papers that do not meet the criteria for inclusion, the reason(s) for exclusion will be recorded. Regarding papers that potentially do meet the criteria, the full texts of the articles were retrieved and read independently by two reviewers to confirm/refute a basis for inclusion. Disagreement will be resolved with discussion and consensus with referral to a third member.
Then, we will map values important to terminally ill patients with cancer and their families in decision-making regarding artificial hydration.


Management information

Registered date

2025 Year 06 Month 05 Day

Last modified on

2025 Year 06 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066034